Back
Amgen, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
39
AMGN
Amgen, Inc.
Last Price:
$326.09
Seasonality Move:
3.66%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atAmgen, Inc. Stock Forecast
-
Over the next 52 weeks, Amgen, Inc. has on average historically risen by 30% based on the past 42 years of stock performance.
-
Amgen, Inc. has risen higher in 28 of those 42 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Amgen, Inc. Stock Undervalued?The current Amgen, Inc. [AMGN] share price is $326.10. The Score for AMGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Amgen, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Amgen, Inc. has on average historically risen by 30% based on the past 42 years of stock performance.
Amgen, Inc. Stock Rating
Sell
39
Amgen, Inc. (AMGN)
is a Sell
Is Amgen, Inc. overpriced?
-
Amgen, Inc. has risen higher in 28 of those 42 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Amgen, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amgen.com
52-Week Data
52-Week High:
346.38
52-Week Low:
260.55
Prediction Charts
Market Cap:
175.6B
Price in USD:
326.10
Volume:
2.1M
Beta:
0.75
Technical Analysis
SMA50:
327.35
SMA100:
307.67
SMA200:
298.16
52-Wk Change:
23.42%
Stock Predictions
-
Is Amgen, Inc. stock public?Yes, Amgen, Inc. is a publicly traded company.
-
What is the Amgen, Inc. stock quote today?The Amgen, Inc. stock price is 326.10 USD today.
-
How to buy Amgen, Inc. stock online?You can buy Amgen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 325.55 | 327.38 | 331.50 | 324.73 |
| Dec-22 | 327.01 | 331.39 | 331.88 | 326.08 |
| Dec-23 | 328.09 | 331.49 | 333.67 | 328.07 |
| Dec-24 | 330.72 | 333.96 | 334.38 | 330.72 |
| Dec-26 | 333.65 | 332.93 | 333.98 | 330.85 |
| Dec-29 | 332.46 | 329.63 | 333.50 | 329.47 |
| Dec-30 | 328.65 | 328.69 | 329.77 | 325.83 |
| Dec-31 | 328.69 | 327.31 | 329.50 | 327.06 |
| Jan-2 | 328.77 | 327.64 | 329.19 | 325.01 |
| Jan-5 | 324.92 | 320.72 | 326.52 | 318.21 |
| Jan-6 | 319.49 | 330.17 | 330.94 | 318.83 |
| Jan-7 | 332.10 | 341.64 | 343.05 | 332.10 |
| Jan-8 | 337.76 | 330.11 | 341.46 | 328.21 |
| Jan-9 | 328.81 | 326.10 | 332.08 | 323.89 |
Amgen, Inc. Earnings
Amgen, Inc. Earnings Report: Per Share Amgen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amgen, Inc. Forecast Revenue Growth
Amgen, Inc. Stock Analysis: Historical quarterly revenues per share for Amgen, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.74 per share.
* Amgen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.